Enterprise Associates 14 New's Net Worth
Enterprise Associates 14 New's net worth is estimated to be at least $71,591,849.10 as of 11/20/2024. CoreStreet's estimation of Enterprise Associates 14 New's net worth is based on their sale of stock and current holding of stock.
Enterprise Associates 14 New is Major Shareholder at Imara Inc. They have executed at least 26 trades of stock as per SEC Form 4 filings. Their most recent trade was for 439,088 units of IMRA stock on 04/05/2022. Their biggest sale was on 03/06/2020 when they sold 708,155 units of Champions Oncology Inc stock for $4,950,003.45. They typically trade 4 times per year.
Total value of insider buys:
- $65,459,130.10
Total value of insider sells:
- $6,132,719.00
Most recent insider trade:
- April 5, 2022
Enterprise Associates 14 New's Insider Trading History
| Imara Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 5, 2022 | Major Shareholder | 439,088 | $1.07 | Sell | $469,824.16 |
Jan. 24, 2022 | Major Shareholder | 19,984 | $1.55 | Sell | $30,975.20 |
Jan. 20, 2022 | Major Shareholder | 6,295 | $1.81 | Sell | $11,393.95 |
Jan. 18, 2022 | Major Shareholder | 6,848 | $1.89 | Sell | $12,942.72 |
Jan. 14, 2022 | Major Shareholder | 9,707 | $1.91 | Sell | $18,540.37 |
Jan. 12, 2022 | Major Shareholder | 4,634 | $2.02 | Sell | $9,360.68 |
Jan. 10, 2022 | Major Shareholder | 1,751 | $2.00 | Sell | $3,502.00 |
Jan. 7, 2022 | Major Shareholder | 14,600 | $2.08 | Sell | $30,368.00 |
Jan. 5, 2022 | Major Shareholder | 8,200 | $2.25 | Sell | $18,450.00 |
Jan. 3, 2022 | Major Shareholder | 44,665 | $2.34 | Sell | $104,516.10 |
Dec. 29, 2021 | Major Shareholder | 15,196 | $2.30 | Sell | $34,950.80 |
Dec. 27, 2021 | Major Shareholder | 27,651 | $2.42 | Sell | $66,915.42 |
Dec. 22, 2021 | Major Shareholder | 20,109 | $2.32 | Sell | $46,652.88 |
Dec. 20, 2021 | Major Shareholder | 85,123 | $2.26 | Sell | $192,377.98 |
Dec. 15, 2021 | Major Shareholder | 28,817 | $2.28 | Sell | $65,702.76 |
Dec. 13, 2021 | Major Shareholder | 17,501 | $2.83 | Sell | $49,527.83 |
Dec. 9, 2021 | Major Shareholder | 5,666 | $2.95 | Sell | $16,714.70 |
| Champions Oncology Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 6, 2020 | Major Shareholder | 708,155 | $6.99 | Sell | $4,950,003.45 |
| Galera Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 12, 2019 | Major Shareholder | 416,666 | $11.79 | Buy | $4,912,492.14 |
| Merit Medical Systems Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 4, 2019 | Major Shareholder | 935,000 | $15.59 | Buy | $14,576,650.00 |
| Mersana Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 5, 2019 | Major Shareholder | 3,750,000 | $4.00 | Buy | $15,000,000.00 |
| Adaptimmune Therapeutics Plc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 7, 2018 | Major Shareholder | 3,000,000 | $1.67 | Buy | $5,010,000.00 |
March 27, 2018 | Major Shareholder | 6,571,164 | $1.92 | Buy | $12,616,634.88 |
March 23, 2018 | Major Shareholder | 1,268,508 | $1.91 | Buy | $2,422,850.28 |
March 27, 2017 | Major Shareholder | 12,870,000 | $0.70 | Buy | $9,009,000.00 |
| TRACON Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 27, 2018 | Major Shareholder | 707,964 | $2.70 | Buy | $1,911,502.80 |